The Effect of Cataract Surgery on Sleep Quality

Sponsor
Sun Yat-sen University (Other)
Overall Status
Unknown status
CT.gov ID
NCT02593669
Collaborator
Ministry of Health, China (Other)
10,000
1
2
35
285.8

Study Details

Study Description

Brief Summary

A cataract is a clouding of the crystalline lens inside the eye, which leads to a decrease in vision. It is the most prevalent, treatable cause of visual impairment and blindness in the world. Cataract surgery with an intraocular lens (IOL) implant is one of the most common and thought to be the most effective surgical procedure in any field of medicine. In this trial, the investigators aimed to evaluate the effect of cataract surgery on circadian rhythm and sleep as well as the effect of the blue light transmission characteristics of the implanted IOL on sleep.

Condition or Disease Intervention/Treatment Phase
  • Procedure: Phacomulsification lens removal cataract surgery with neutral Intraocular lens(IOL) implantation
  • Procedure: Phacomulsification lens removal cataract surgery with blue-blocking Intraocular lens(IOL) implantation
  • Drug: Subconjunctival dexamethasone and general anesthesia
  • Drug: Viscoelastic materials
N/A

Detailed Description

A Prospective, randomized controlled study of 10000 participants(20000 eyes) with dense nucleus were enrolled. Patients were assigned to two groups: Group I: neutral IOL implanted in eye while in Group II, blue-blocking IOL was innovatively implanted in the eye.

A cataract is a clouding of the crystalline lens inside the eye, which leads to a decrease in vision. It is the most prevalent, treatable cause of visual impairment and blindness in the world. Cataract surgery with an intraocular lens (IOL) implant is one of the most common and thought to be the most effective surgical procedure in any field of medicine.

In this trial, the investigators aimed to evaluate the effect of cataract surgery on circadian rhythm and sleep as well as the effect of the blue light transmission characteristics of the implanted IOL on sleep. Patients enrolled into the study will be assessed in 3 months before the surgery and 3 months after the surgery.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
10000 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Outcomes Assessor)
Primary Purpose:
Treatment
Official Title:
The Effect of Cataract Surgery for Age-related Cataract Patients on Circadian Rhythm and Sleep Quality
Study Start Date :
Jan 1, 2016
Anticipated Primary Completion Date :
Dec 1, 2018
Anticipated Study Completion Date :
Dec 1, 2018

Arms and Interventions

Arm Intervention/Treatment
Experimental: Neutral IOL

Phacoemulsification cataract surgery is performed with neutral IOL implantation.

Procedure: Phacomulsification lens removal cataract surgery with neutral Intraocular lens(IOL) implantation
The phacoemulsification lens removal cataract surgery is performed with neutral IOL.implantation

Drug: Subconjunctival dexamethasone and general anesthesia
All patients received subconjunctival dexamethasone (2 mg) during surgery, and all surgeries were performed under general anesthesia.

Drug: Viscoelastic materials
viscoelastic materials are used to protect corneal endothelial cells.

Experimental: Blue-blocking IOL

Phacoemulsification cataract surgery is performed with blue-blocking IOL implantation.

Procedure: Phacomulsification lens removal cataract surgery with blue-blocking Intraocular lens(IOL) implantation
The phacoemulsification lens removal cataract surgery is performed with blue-blocking IOL.implantation.

Drug: Subconjunctival dexamethasone and general anesthesia
All patients received subconjunctival dexamethasone (2 mg) during surgery, and all surgeries were performed under general anesthesia.

Drug: Viscoelastic materials
viscoelastic materials are used to protect corneal endothelial cells.

Outcome Measures

Primary Outcome Measures

  1. Change from Post-illumination pupil response (PIPR) [3 months before the surgery and 3 months after the surgery]

  2. Change from Objective sleep quality:actigraphy [3 months before the surgery and 3 months after the surgery]

  3. Change from Subjective sleep quality: PSQI [3 months before the surgery and 3 months after the surgery]

Eligibility Criteria

Criteria

Ages Eligible for Study:
N/A and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Bilateral age-related cataract scheduled for cataract surgery
Exclusion Criteria:
  • Vision-impairing ophthalmic disease: Glaucoma, AMD, DR.et.al

  • Severe systemic disease: Diabetes, Sleep disorder.et.al

  • Vision-impairing complications: Ruptured posterior capsule, Persistent cornea edema.et.al

Contacts and Locations

Locations

Site City State Country Postal Code
1 Zhongshan Ophthalmic Center, Sun Yat-sen University Guangzhou Guangdong China 510060

Sponsors and Collaborators

  • Sun Yat-sen University
  • Ministry of Health, China

Investigators

  • Principal Investigator: Haotian Lin, M.D., Ph.D, Zhongshan Ophthalmic Center, Sun Yat-sen University
  • Study Chair: Yizhi Liu, M.D., Ph.D, Zhongshan Ophthalmic Center, Sun Yat-sen University
  • Study Director: Weirong Chen, M.D., Zhongshan Ophthalmic Center, Sun Yat-sen University

Study Documents (Full-Text)

None provided.

More Information

Additional Information:

Publications

Responsible Party:
Haotian Lin, Principal Investigator, Home for Cataract Children, Zhongshan Ophthalmic Center, Sun Yat-sen University
ClinicalTrials.gov Identifier:
NCT02593669
Other Study ID Numbers:
  • CCPMOH2010-China8
First Posted:
Nov 1, 2015
Last Update Posted:
Nov 1, 2015
Last Verified:
Oct 1, 2015
Additional relevant MeSH terms:

Study Results

No Results Posted as of Nov 1, 2015